References of "Reginster, Jean-Yves"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailIncidence des perturbations psychoendocriniennes au centre interdisciplinaire de l’andropause (CIA) du CHU de Liège : bilan des 7 premiers mois d’activité
Allouch, A; Bruwier, M; Comte-Tassin, M et al

in Annales d'Endocrinologie (2001), 62(4), 178

Detailed reference viewed: 18 (5 ULg)
Full Text
Peer Reviewed
See detailA simple clinical tool to identify Asian women with osteoporosis
Lou, SQ; Koh, L; Yang, BY et al

in Journal of Rheumatology (2001), 28(S63), 26

Detailed reference viewed: 6 (1 ULg)
Full Text
Peer Reviewed
See detailThe effect of risedronate on hip fracture risk in elderly women with osteoporosis
Bensen, W; Eastell, R; Reginster, Jean-Yves ULg et al

in Journal of Rheumatology (2001), 28(S63), 24

Detailed reference viewed: 6 (1 ULg)
Full Text
Peer Reviewed
See detailStand der osteoporose-Therapie. Ein Medizinischer Skandal
Reginster, Jean-Yves ULg

in MMW Fortschritte der Medizin (2001), 143(14), 43

Detailed reference viewed: 13 (1 ULg)
Full Text
Peer Reviewed
See detailRisedronate Increases Bone Mineral Density and Reduces the Vertebral Fracture Incidence in Postmenopausal Women
Reginster, Jean-Yves ULg

in Clinical and Experimental Rheumatology (2001), 19(1), 121-2

Detailed reference viewed: 10 (1 ULg)
Full Text
Peer Reviewed
See detailThe expression of IL-1β, iNOS and COX-2 genes by human chondrocytes is differentially regulated by reactive oxygen species
Henrotin, Yves ULg; Mathy, M; Deby, G et al

in Tissue Engineering (2001), 7

Detailed reference viewed: 17 (1 ULg)
Full Text
Peer Reviewed
See detailThe expression of IL-1 β, iNOS and COX-2 genes by human chondrocytes is differentially regulated by reactive oxygen species
Mathy-Hartert, M; Deby, GP; Ayache, N et al

in Osteoarthritis and Cartilage (2001), 9SB

Detailed reference viewed: 11 (1 ULg)
Full Text
Peer Reviewed
See detailInterleukine-1 β regulation of transforming growth factor-β1 expression in articular chondrocytes : influence of aceclofenac
Andriamanalijaona, R; Ayache, N; Mathy-Hartert, M et al

in Osteoarthritis and Cartilage (2001), 9SB

Detailed reference viewed: 5 (1 ULg)
Full Text
Peer Reviewed
See detailExpression of transforming growth factors and their receptors is differentially modulated by reactive oxygen species and nitric oxide in human articular chondocytes
Ayache, N; Boumediene, K; Mathy-Hartert, M et al

in Osteoarthritis and Cartilage (2001), 9SB

Detailed reference viewed: 5 (1 ULg)
Full Text
Peer Reviewed
See detailPrevention of early postmenopausal bone loss by strontium ranelate : a randomised, two-year, double-blind, placebo-controlled trial
Reginster, Jean-Yves ULg; DEROISY, Rita ULg; Tsouderos, Y et al

in Journal of Bone and Mineral Research (2001), 16(S1), 219

Detailed reference viewed: 15 (1 ULg)
Full Text
Peer Reviewed
See detailEfficacy of risedronate in decreasing the incidence of femoral neck and intertrochanteric fractures in older women with osteoporosis
Eastell, R; McClung, MR; Reginster, Jean-Yves ULg et al

in Journal of Bone and Mineral Research (2001), 16(S1), 219

Detailed reference viewed: 8 (1 ULg)
Full Text
Peer Reviewed
See detailSustained fracture risk reduction over 5 years with risedronate therapy
Watts, NB; Brown, J; Hosking, D et al

in Journal of Bone and Mineral Research (2001), 16(S1), 217

Detailed reference viewed: 9 (1 ULg)
Full Text
Peer Reviewed
See detailEffect of risedronate on the risk of hip fracture in elderly women
McClung, MR; Geusens, P; Miller, PD et al

in Clinical Rheumatology (2001), 20

Detailed reference viewed: 28 (2 ULg)
Full Text
Peer Reviewed
See detailStrontium ranelate : dose-dependent effects in postmenopausal osteoporosis : the STRATOS 2-year randomised trial
Reginster, Jean-Yves ULg; Slosman, DO; Delmas, PD et al

in Clinical Rheumatology (2001), 20

Detailed reference viewed: 8 (1 ULg)